31.59MMarket Cap-248P/E (TTM)
2.240High2.150Low280.86KVolume2.220Open2.200Pre Close617.93KTurnover2.51%Turnover RatioLossP/E (Static)14.36MShares23.90052wk High2.12P/B24.61MFloat Cap0.77152wk Low--Dividend TTM11.19MShs Float450.000Historical High--Div YieldTTM4.09%Amplitude0.770Historical Low2.200Avg Price1Lot Size
Longeveron Stock Forum
MIAMI, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that its submission entitled “Lomecel-B inhibition of MMP14 activ...
No comment yet